Despite progress, India still had the highest TB burden, accounting for almost a quarter of global cases in 2025
Following a US FDA warning over a rare vision-loss condition, specialists say the absolute risk remains low, while the metabolic and cardiovascular benefits of GLP-1 drugs are substantial
The US regulator has called for new eye-related warnings on GLP-1 drug labels, but Indian safety data remains limited
Global review covering over 200 million participant observations links prolonged PM2.5 exposure to higher Type 2 diabetes risk, highlighting metabolic health concerns in polluted regions
Doctors question whether Temple can reliably measure brain blood flow, while Goyal defends its research, saying the ₹85,000 wearable is a fitness and AI product, not a medical device
The US FDA will add a warning about non-arteritic anterior ischemic optic neuropathy, a rare eye condition that can cause significant and sometimes permanent vision loss, to the labels of GLP-1 drugs
The tentative approval for generic lenacapavir is expected to accelerate affordable access to the twice-yearly HIV prevention injection across 120 countries outside the US.
US regulators have approved a generic version of lenacapavir, a long-acting HIV-prevention drug, for sale in low-income countries, potentially widening access to preventive treatment.
Antihistamines work by blocking histamine, a chemical released by the immune system during an allergic reaction
While its advantages for strength and athletic performance are supported by evidence, it's increasingly being recommended for its mental health effects
The Health Ministry has replaced the 60 per cent residual shelf-life requirement with a fixed 12-month minimum for most imported drugs, aiming to ease imports and reduce wastage
Major innovator brands see no price reductions despite cuts of up to 93 per cent for some cancer medicines; patient groups say PAP exclusions and data gaps have diluted relief
The Supreme Court questioned steep hospital mark-ups on cancer medicines and medical consumables, criticised the Centre's pricing framework and reserved its verdict on a plea seeking tighter controls
Blume Ventures and South Park Commons led the funding round as Cent plans to expand its AI-powered medical imaging, diagnostics and preventive healthcare services in India
Takotsubo cardiomyopathy can temporarily weaken the heart after intense emotional or physical stress, mimicking a heart attack
AIMED calls for stricter inspections, traceable disposal records and clear liability rules to protect patient safety
France has reported the first documented human infection with the Shamonda virus. There is no evidence of human-to-human transmission, but investigations into the case continue
The Bhubaneswar-based healthtech firm raised Rs 69 crore in equity and over Rs 30 crore in debt to expand its rural clinic network and strengthen AI-powered healthcare services
New prices set to come into effect from November 9, 2026; state drug controllers to monitor implementation
A study of 13,825 people found that 53 per cent had experienced mental health concerns for over a year before reaching the provider, highlighting barriers to timely care